GHRS GH Research PLC

Price (delayed)

$25.96

Market cap

$1.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1

Enterprise value

$1.44B

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary ...

Highlights
GH Research's debt has decreased by 44% YoY and by 17% QoQ
GH Research's equity has increased by 36% QoQ and by 19% YoY
The quick ratio rose by 25% QoQ but it fell by 3.5% YoY
GH Research's net income has plunged by 52% YoY and by 10% from the previous quarter
GHRS's EPS is down by 35% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of GHRS

GHRS stock price

How has the GH Research stock price performed over time
Intraday
-6.82%
1 week
-6.45%
1 month
-8.37%
1 year
90.18%
YTD
104.41%
QTD
-3.42%

Financial performance

How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$71.49M
Net income
-$62.27M
Gross margin
N/A
Net margin
N/A
GH Research's net income has plunged by 52% YoY and by 10% from the previous quarter
GH Research's operating income has decreased by 35% YoY and by 7% from the previous quarter

Price vs fundamentals

How does GHRS's price correlate with its fundamentals

Growth

What is GH Research's growth rate over time

Valuation

What is GH Research stock price valuation
P/E
N/A
P/B
4.48
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 35% year-on-year and by 9% since the previous quarter
The price to book (P/B) is 78% more than the 5-year quarterly average of 2.7 and 37% more than the last 4 quarters average of 3.5
GH Research's equity has increased by 36% QoQ and by 19% YoY

Efficiency

How efficient is GH Research business performance
GHRS's return on invested capital is down by 45% since the previous quarter
The return on assets has declined by 25% year-on-year and by 5% since the previous quarter
GHRS's return on equity is down by 25% year-on-year and by 6% since the previous quarter

Dividends

What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GHRS.

Financial health

How did GH Research financials performed over time
GH Research's total assets has increased by 35% from the previous quarter and by 19% YoY
The quick ratio rose by 25% QoQ but it fell by 3.5% YoY
GH Research's debt is 100% lower than its equity
GH Research's debt has decreased by 44% YoY and by 17% QoQ
GH Research's equity has increased by 36% QoQ and by 19% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.